{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:22:27Z","timestamp":1789712547247,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T00:00:00Z","timestamp":1433808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Swedish Cancer Society (CAN 2011\/599)"},{"DOI":"10.13039\/100002002","name":"Cancer Research Foundation (LP 13-1980)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Faculty, Ume\u00e5 University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.yexcr.2015.05.012","type":"journal-article","created":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T20:42:25Z","timestamp":1432327345000},"page":"23-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells"],"prefix":"10.1016","volume":"336","author":[{"given":"Andreas","family":"Tyler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terese","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Kumar","family":"Gudey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Br\u00e4nnstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Grankvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parviz","family":"Behnam-Motlagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2015.05.012_bib1","first-page":"1439","article-title":"Mechanism of action of cis-dichlorodiammineplatinum(II)","volume":"63","author":"Zwelling","year":"1979","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.yexcr.2015.05.012_bib2","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2015.05.012_bib3","first-page":"35","article-title":"Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance","volume":"2","author":"Andrews","year":"1990","journal-title":"Cancer Cells"},{"key":"10.1016\/j.yexcr.2015.05.012_bib4","first-page":"573","article-title":"Why target apoptosis in cancer treatment?","volume":"2","author":"Kasibhatla","year":"2003","journal-title":"Mol. Cancer Ther."},{"issue":"Suppl.","key":"10.1016\/j.yexcr.2015.05.012_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s002800051053","article-title":"Multidrug resistance: molecular mechanisms and clinical relevance","volume":"40","author":"Ling","year":"1997","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.yexcr.2015.05.012_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<17::AID-JCP2>3.0.CO;2-U","article-title":"Cell-cycle-dependent turnover of P-glycoprotein in multidrug-resistant cells","volume":"184","author":"Zhang","year":"2000","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.yexcr.2015.05.012_bib7","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2015.05.012_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2015.05.012_bib9","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0959-437X(96)80091-8","article-title":"P-glycoprotein and multidrug resistance","volume":"6","author":"Gottesman","year":"1996","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.yexcr.2015.05.012_bib10","first-page":"973","article-title":"Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity","volume":"2","author":"Aksentijevich","year":"1996","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2015.05.012_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tips.2005.01.002","article-title":"Mechanisms of platinum drug resistance","volume":"26","author":"Ohmichi","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.yexcr.2015.05.012_bib12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1096\/fj.00-0223com","article-title":"Ceramide glycosylation potentiates cellular multidrug resistance","volume":"15","author":"Liu","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.yexcr.2015.05.012_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0968-0004(92)90489-V","article-title":"The ATP-dependent glutathione S-conjugate export pump","volume":"17","author":"Ishikawa","year":"1992","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.yexcr.2015.05.012_bib14","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1096\/fj.07-092981","article-title":"A role for ceramide in driving cancer cell resistance to doxorubicin","volume":"22","author":"Liu","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.yexcr.2015.05.012_bib15","doi-asserted-by":"crossref","first-page":"25315","DOI":"10.1074\/jbc.M002630200","article-title":"Cloning of Gb3 synthase, the key enzyme in globo-series glycosphingolipid synthesis, predicts a family of alpha 1, 4-glycosyltransferases conserved in plants, insects, and mammals","volume":"18","author":"Keusch","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2015.05.012_bib16","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1091\/mbc.E05-11-1035","article-title":"The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect","volume":"17","author":"Smith","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.yexcr.2015.05.012_bib17","first-page":"2901","article-title":"Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation","volume":"94","author":"LaCasse","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2015.05.012_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2407-9-67","article-title":"Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis","volume":"9","author":"Johansson","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2015.05.012_bib19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF00191346","article-title":"Expression of the glycolipid globotriaosylceramide (Gb3) in testicular carcinoma in situ","volume":"426","author":"Kang","year":"1995","journal-title":"Virchows Arch."},{"key":"10.1016\/j.yexcr.2015.05.012_bib20","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1073\/pnas.0506474102","article-title":"The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer","volume":"102","author":"Kovbasnjuk","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2015.05.012_bib21","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1074\/jbc.275.9.6246","article-title":"Retroviral transfection of Madin-Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 10(5)- to 10(6)-fold increased cell sensitivity to verocytotoxin. Role of p-glycoprotein in glycolipid synthesis","volume":"275","author":"Lala","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2015.05.012_bib22","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.1074\/jbc.M305645200","article-title":"Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis","volume":"279","author":"De Rosa","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2015.05.012_bib23","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1074\/jbc.M705473200","article-title":"Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog","volume":"283","author":"De Rosa","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2015.05.012_bib24","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/j.1742-4658.2006.05223.x","article-title":"Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1. Cyclosporin A can lower serum and liver globotriaosyl ceramide levels in the Fabry mouse model","volume":"273","author":"Mattocks","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.yexcr.2015.05.012_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1026553626537","article-title":"Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences","volume":"17","author":"Lavie","year":"2000","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.yexcr.2015.05.012_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1476-4598-9-145","article-title":"Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling","volume":"9","author":"Liu","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2015.05.012_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/sj.bjc.6605467","article-title":"Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells","volume":"102","author":"Johansson","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2015.05.012_bib28","first-page":"1955","article-title":"Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues","volume":"42","author":"Marklund","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2015.05.012_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","article-title":"Global cancer statistics in the year 2000","volume":"2","author":"Parkin","year":"2001","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.yexcr.2015.05.012_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.53.1.5","article-title":"Cancer statistics, 2003","volume":"53","author":"Jemal","year":"2003","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2015.05.012_bib32","first-page":"3986","article-title":"Akt\/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation","volume":"61","author":"Brognard","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2015.05.012_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1440-1843.2004.00602.x","article-title":"Mesothelial cell proliferation and apoptosis","volume":"9","author":"Leard","year":"2004","journal-title":"Respirology"},{"key":"10.1016\/j.yexcr.2015.05.012_bib34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.yexcr.2015.05.012_bib35","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/00498250701867889","article-title":"Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition","volume":"38","author":"Zhou","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.yexcr.2015.05.012_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00280-004-0868-0","article-title":"Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine","volume":"55","author":"Jin","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.yexcr.2015.05.012_bib37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.plipres.2010.10.003","article-title":"Sphingolipids and expression regulation of genes in cancer","volume":"50","author":"Patwardhan","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.yexcr.2015.05.012_bib38","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.bbamem.2006.08.012","article-title":"Glycosphingolipids and drug resistance","volume":"1758","author":"Gouaze-Andersson","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2015.05.012_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/B978-0-12-394274-6.00003-0","article-title":"Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance","volume":"117","author":"Liu","year":"2013","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.yexcr.2015.05.012_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1751-7915.2010.00180.x","article-title":"Shiga toxin and its use in targeted cancer therapy and imaging","volume":"4","author":"Engedal","year":"2011","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.yexcr.2015.05.012_bib41","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1091\/mbc.12.8.2453","article-title":"Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes","volume":"12","author":"Falgui\u00e8res","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.yexcr.2015.05.012_bib42","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0021-9258(17)31302-9","article-title":"Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidase of 28S RNA when microinjected into Xenopus oocytes","volume":"264","author":"Saxena","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2015.05.012_bib43","first-page":"475","article-title":"Glucosylceramide: a marker for multiple-drug resistant cancers","volume":"18","author":"Lucci","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/j.yexcr.2015.05.012_bib44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/1097-0215(20000715)87:2<172::AID-IJC3>3.0.CO;2-K","article-title":"Differential expression of sphingolipids in MRP1 overexpressing HT29 cells","volume":"87","author":"Kok","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2015.05.012_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.1449","article-title":"Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets","volume":"94","author":"Morjani","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2015.05.012_bib46","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1096\/fj.01-0863fje","article-title":"Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus","volume":"16","author":"Veldman","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.yexcr.2015.05.012_bib47","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-04-2329","article-title":"Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs","volume":"65","author":"Gouaz\u00e9","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2015.05.012_bib48","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1600-0854.2009.00919.x","article-title":"Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin","volume":"10","author":"Raa","year":"2009","journal-title":"Traffic"},{"key":"10.1016\/j.yexcr.2015.05.012_bib49","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1158\/1535-7163.633.3.5","article-title":"Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy","volume":"3","author":"Gouaz\u00e9","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.yexcr.2015.05.012_bib50","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1177\/35.12.2890686","article-title":"Immunocytochemical localization of P170 at the plasma membrane of multidrug-resistant human cells","volume":"35","author":"Willingham","year":"1987","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.yexcr.2015.05.012_bib51","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0145-2126(00)00048-5","article-title":"Identification of the subcellular localization of daunorubicin in multidrug-resistant K562 cell line","volume":"24","author":"Gong","year":"2000","journal-title":"Leuk. Res."},{"key":"10.1016\/j.yexcr.2015.05.012_bib52","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1016\/j.yexcr.2006.09.005","article-title":"P-gp localization in mitochondria and its functional characterization in multiple drug-resistant cell lines","volume":"312","author":"Solazzo","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2015.05.012_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1768-322X.1999.tb01080.x","article-title":"P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells","volume":"91","author":"Maraldi","year":"1999","journal-title":"Biol. Cell"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482715001925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482715001925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T20:49:19Z","timestamp":1691700559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482715001925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0014482715001925"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2015.05.012","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting glucosylceramide synthase induction of cell surface globotriaosylceramide (Gb3) in acquired cisplatin-resistance of lung cancer and malignant pleural mesothelioma cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2015.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}